financetom
Business
financetom
/
Business
/
GGL Resources Updates Its Earn-In Agreement With Nelson Resources for the Gold Point Project
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GGL Resources Updates Its Earn-In Agreement With Nelson Resources for the Gold Point Project
Mar 16, 2026 1:33 PM

04:13 PM EDT, 03/16/2026 (MT Newswires) -- GGL Resources ( GGLXF ) on Monday updated the status of its agreement with Australian Securities Exchange-listed Nelson Resources (NES), by which NES can acquire up to a 90% interest in GGL's high-grade, gold-silver Gold Point Project located in the Walker Lane District, Nevada.

This agreement is subject to TSX Venture Exchange acceptance as well as GGL obtaining disinterested shareholder approval by way of written consents from disinterested shareholders holding greater than 50% of the total number of shares held by disinterested shareholders, the company said.

As per the acquisition terms, upon completion of the acquisition, NES will acquire an initial 25% interest in the Gold Point Project by making a cash payment of US$191,617 to GGL. It will issue the number of NES shares equivalent to the value of A$325,000 at a deemed issue price equal to the 20-day volume weighted average price of shares trading on the ASX immediately prior to the date of the binding documentation / announcement of the transaction.

Subject to the completion of the acquisition, NES will have the exclusive right to earn up to a 90% collective interest in the Gold Point Project subject to satisfying aggregate earn-in expenditures of US$3 million. It will make consideration payments to GGL in various tranches.

GGL's shares were last seen unchanged at C$0.06 on the TSX Venture Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Renault, Geely create joint venture for hybrid, combustion engines
Renault, Geely create joint venture for hybrid, combustion engines
May 30, 2024
(Reuters) -French automaker Renault and Chinese partner Geely announced a highly anticipated joint venture on Friday that will develop combustion and hybrid engines, aiming to improve the competitiveness of their legacy auto business. The 50-50 venture is a core element of Renault's strategy to stay in the race against larger competitors by signing multiple partnerships to reduce costs and access...
Indonesia to issue copper export permits for Freeport, Amman, official says
Indonesia to issue copper export permits for Freeport, Amman, official says
May 30, 2024
JAKARTA, May 31 (Reuters) - Indonesia will issue copper concentrate export permits for miner Freeport Indonesia and Amman Mineral Internasional, a trade ministry official said on Friday, ensuring that exports by both companies would not be disrupted. Freeport's and Amman's current export permits expire on Friday. The permits will take effect from June 1, Budi Santoso, the trade ministry's director...
Employees at some businesses in Russia's Tatarstan region have been evacuated, says state media
Employees at some businesses in Russia's Tatarstan region have been evacuated, says state media
May 30, 2024
May 31 (Reuters) - Employees at several businesses in Russia's Tatarstan region and its administrative centre of Kazan have been evacuated for safety reasons, Russian state news agencies reported on Friday, citing local officials. Airports in the cities of Kazan and Nizhnekamsk in the same region have also imposed temporary flight restrictions for safety reasons, a representative for Rosaviatsia, the...
FDA extends deadline, requests more data on Sanofi's Dupixent for treating 'smoker's lung'
FDA extends deadline, requests more data on Sanofi's Dupixent for treating 'smoker's lung'
May 30, 2024
May 31 (Reuters) - French drugmaker Sanofi and its partner Regeneron said on Friday the U.S. Food and Drug Administration (FDA) requested additional analyses on the efficacy of Dupixent as an add-on treatment in certain patients 'smoker's lung', or COPD. As a result, the deadline for the review was pushed back by three months, to September 27. Sanofi last year...
Copyright 2023-2026 - www.financetom.com All Rights Reserved